AI assistant
INSMED Inc — Director's Dealing 2025
Jun 12, 2025
30150_dirs_2025-06-12_b9f8a4e9-b1d7-42cd-9988-7f90298389fa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-06-10
Reporting Person: Schaeffer Orlov S Nicole (Chief People Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-10 | Common Stock | M | 38300 | $17.16 | Acquired | 156879 | Direct |
| 2025-06-10 | Common Stock | S | 38300 | $88.64 | Disposed | 118579 | Direct |
| 2025-06-11 | Common Stock | M | 70000 | $13.91 | Acquired | 188579 | Direct |
| 2025-06-11 | Common Stock | S | 35072 | $91.68 | Disposed | 153507 | Direct |
| 2025-06-11 | Common Stock | S | 18319 | $92.73 | Disposed | 135188 | Direct |
| 2025-06-11 | Common Stock | S | 10781 | $93.48 | Disposed | 124407 | Direct |
| 2025-06-11 | Common Stock | S | 34500 | $95.49 | Disposed | 89907 | Direct |
| 2025-06-11 | Common Stock | S | 500 | $96.02 | Disposed | 89407 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-06-10 | Stock Option (right to buy) | $17.16 | M | 38300 | Disposed | 2027-05-17 | Common Stock (38300) | Direct |
| 2025-06-11 | Stock Option (right to buy) | $13.91 | M | 70000 | Disposed | 2029-01-03 | Common Stock (70000) | Direct |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 15, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F3: This is the weighted average sales price representing 35,072 shares sold at prices ranging from $91.18 to $92.17 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4: This is the weighted average sales price representing 18,319 shares sold at prices ranging from $92.20 to $93.19 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5: This is the weighted average sales price representing 10,781 shares sold at prices ranging from $93.20 to $93.77 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F6: This is the weighted average sales price representing 34,500 shares sold at prices ranging from $95.00 to $95.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F7: This is the weighted average sales price representing 500 shares sold at prices ranging from $96.00 to $96.04 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F8: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.